Atherosclerosis
Volume 207, Issue 1 , Pages 8-15 , November 2009

Genetic diversity of CX3CR1 gene and coronary artery disease: New insights through a meta-analysis

  • Stavros Apostolakis

      Affiliations

    • Laboratory of Clinical Virology, Faculty of Medicine, University of Crete, Voutes, 71110 Heraklion, Greece
    • ,
  • Virginia Amanatidou

      Affiliations

    • Laboratory of Clinical Virology, Faculty of Medicine, University of Crete, Voutes, 71110 Heraklion, Greece
    • ,
  • Emmanouil G. Papadakis

      Affiliations

    • Onassis Cardiac Surgery Centre, Athens, Greece
    • ,
  • Demetrios A. Spandidos

      Affiliations

    • Laboratory of Clinical Virology, Faculty of Medicine, University of Crete, Voutes, 71110 Heraklion, Greece
    • Corresponding Author InformationCorresponding author. Tel.: +30 2810 394631; fax: +30 2810 394759.

Received 11 February 2009 ,Revised 6 March 2009 ,Accepted 24 March 2009.

References 

  1. Luster AD. Chemokines—chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338:436–445
  2. Curnock AP, Logan MK, Ward SG. Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases. Immunology. 2002;105:125–136
  3. Reape TJ. Chemokines and atherosclerosis. Atherosclerosis. 1999;147:213–225
  4. Zernecke A, Shagdarsuren E, Weber C. Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol. 2008;28:1897–1908
  5. Apostolakis S, Papadakis GE, Krambovitis E, Spandidos DA. Chemokines in vascular pathology. Int J Mol Med. 2006;17:691–701
  6. Imai T, Hieshima K, Haskell C, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell. 1997;91:521–530
  7. Bazan JF, Bacon KB, Hardiman G, et al. A new class of membranebound chemokine with a CX3C motif. Nature. 1997;385:640–644
  8. Wong BWC, Wong D, McManus BM. Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease. Cardiovasc Pathol. 2002;11:332–338
  9. Lesnik P, Haskell CA, Charo IF. Decreased atherosclerosis in CX3CR1−/− mice reveals a role for fractalkine in atherogenesis. J Clin Invest. 2003;111:333–340
  10. Combadière C, Potteaux S, Gao JL, et al. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation. 2003;107:1009–1016
  11. Landsman L, Bar-On L, Zernecke A, et al. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood. 2009;22:963–972
  12. Faure S, Meyer L, Costagliola D, et al. Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science. 2000;287:2274–2277
  13. Moatti D, Faure S, Fumeron F, et al. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood. 2001;97:1925–1928
  14. McDermott DH, Fong AM, Yang Q, et al. Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J Clin Invest. 2003;111:1241–1250
  15. Daoudi M, Lavergne E, Garin A, et al. Enhanced adhesive capacities of the naturally occurring Ile249–Met280 variant of the chemokine receptor CX3CR1. J Biol Chem. 2004;279:19649–19657
  16. Nassar BA, Nanji AA, Ransom TP, et al. Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors. Scand J Clin Lab Invest. 2008;68:286–291
  17. Apostolakis S, Baritaki S, Kochiadakis GE, Igoumenidis NE, Panutsopulos D, Spandidos DA. Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease. Thromb Res. 2007;119:63–71
  18. Niessner A, Marculescu R, Kvakan H, et al. Fractalkine receptor polymorphisms V2491 and T280M as genetic risk factors for restenosis. Thromb Haemost. 2005;94:1251–1256
  19. Rios DL, Callegari-Jacques SM, Hutz MH. Endothelial nitric oxide synthase and fractalkine chemokine receptor polymorphisms on angiographically assessed coronary atherosclerosis. Clin Chim Acta. 2005;362:138–146
  20. Hattori H, Ito D, Tanahashi N, et al. T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease. Neurosci Lett. 2005;374:132–135
  21. Ghilardi G, Biondi ML, Turri O, Guagnellini E, Scorza R. Internal carotid artery occlusive disease and polymorphisms of fractalkine receptor CX3CR1: a genetic risk factor. Stroke. 2004;35:1276–1279
  22. Gugl A, Renner W, Seinost G, et al. Two polymorphisms in the fractalkine receptor CX3CR1 are not associated with peripheral arterial disease. Atherosclerosis. 2003;166:339–343
  23. Niessner A, Marculescu R, Haschemi A, et al. Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome: a possible implication of fractalkine in inflammatory activation. Thromb Haemost. 2005;93:949–954
  24. McDermott DH, Halcox JP, Schenke WH, et al. Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ Res. 2001;89:401–407
  25. Gaunt TR, Rodríguez S, Day IN. Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool ‘CubeX’. BMC Bioinformatics. 2007;8:428
  26. Lucas AD, Bursill C, Guzik TJ, Sadowski J, Channon KM, Greaves DR. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1). Circulation. 2003;108:2498–2504
  27. Apostolakis S, Krambovitis E, Vlata Z, Kochiadakis GE, Baritaki S, Spandidos DA. CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: impact of pre-inflammatory stimuli and rennin–angiotensin system modulators. Thromb Res. 2007;121:387–395

PII: S0021-9150(09)00256-1

doi: 10.1016/j.atherosclerosis.2009.03.044

Atherosclerosis
Volume 207, Issue 1 , Pages 8-15 , November 2009

Article Tools

* Image Usage & Resolution